Navigation Links
DNA methylation shown to promote development of colon tumors
Date:11/30/2007

determine the impact of inducing methylation on tumor development," says Linhart. "Does it inhibit it, do nothing or promote it""

Surprisingly and importantly, methylation appears to target specific regions of the DNA and the genes within them rather than being distributed randomly. "We found that key tumor-suppressor genes in certain DNA regions were silenced months before tumors appear," says Linhart. This specific targeting extends to organs as well: A given gene that is methylated in the colon, for example, does not become methylated in the spleen. The specificity of the process could prove a major advantage for diagnostic and therapeutic approaches based on DNA methylation.

"The enzymes that silence tumor-suppressing genes would be terrific targets for treatment," says senior author Rudolf Jaenisch. "If we can inactivate them and rescue the cancer-prevention functions of these genes, there would be predictably no side effects. And if we can examine circulating blood for signs of early methylation, we might be able to prevent tumors from developing."

Although this study focused on mice, Jaenisch notes that current clinical trials using a drug to inhibit methylation in people with leukemia appear to delay the disease."


'/>"/>

Contact: Eric Bender
bender@wi.mit.edu
617-258-9183
Whitehead Institute for Biomedical Research
Source:Eurekalert

3

GOOD

Page: 1 2 3

Related biology news :

1. Spaceflight shown to alter ability of bacteria to cause disease
2. Immune cells promote blood vessel formation in mouse endometriosis
3. Regulation of TATA-less promoters
4. Synthetic compound promotes death of lung-cancer cells, tumors
5. Gender, coupled with diabetes, affects vascular disease development
6. New target for anti-flu drug development
7. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
8. KAUST and American University in Cairo to collaborate on research and academic development
9. Old developmental pathways spawn revolutionary evolutionary changes
10. NIST announces 56 new awards for innovative technology research and development
11. Progress Against Malaria: Developments on the Horizon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... most deadly when they metastasize and spread tumors throughout ... becomes very difficult for doctors to locate and treat ... the University of Missouri have found a way to ... they may be in the body. Michael Lewis, an ... Veterinary Medicine, says being able to target secondary tumors ...
(Date:5/21/2013)... pharmacies and health stores, phosphatidylserine is a natural ... Proven to improve cognition and slow memory loss, ... memory impairment. Now a team headed by Prof. ... Aviv University,s Department of Human Molecular Genetics ... the functioning of genes involved in degenerative brain ...
(Date:5/21/2013)... keeping in shape is an uphill battle? Try staying ... prolonged weightlessness withers muscle and bone. , That,s the ... address with a new three-year, $1.2 million grant from ... exercise during multiyear exploratory missions. , "You could give ... you can,t get them to stick to it, it ...
Breaking Biology News(10 mins):MU researchers develop radioactive nanoparticles that target cancer cells 2Common food supplement fights degenerative brain disorders 2Fueling fitness on the final frontier 2
... scientists, working together in a project called PLANTS, sought ... and people to continuously assess the state of crop ... monitors the state of the crop on a plant-by-plant ... a broader vision where the virtual (computing) space was ...
... low-weight preemie at 24 weeks, exhibited the first-found link in ... amniotic fluid of a woman in preterm labor. , Using ... cultured and grown in the lab, researchers from Case Western ... Obstetrics and Gynecology at MetroHealth Medical Center in Cleveland made ...
... you're a health care professional you'd better know the difference--mistakes ... the United States alone are injured each year from medication ... working to reduce the possibilities of these errors, such as ... of Narcan but received Norcuron and went into cardiac arrest. ...
Cached Biology News:New crop of technology reveals plant health 2New crop of technology reveals plant health 3Prenatal nicotine exposure reduces breathing response of newborns... 2Prenatal nicotine exposure reduces breathing response of newborns... 3Computer scientist sorts out confusable drug names 2
(Date:5/23/2013)... -- Northwest Biotherapeutics (NASDAQ: NWBO ) (NW ... immune therapies for solid tumor cancers, announced today that ... Society Of Clinical Oncology (ASCO) meeting in ... immune therapy.  (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ) ... conference focused on clinical treatment of cancer, with attendance ...
(Date:5/23/2013)... May 23, 2013  Verenium Corporation (Nasdaq: ... the development and commercialization of high-performance enzymes, today announced ... Officer, will present at two upcoming conferences. ... present at the Second Annual Marcum LLP Microcap Conference ... Hotel in New York City.  The presentation is scheduled ...
(Date:5/23/2013)... May 23, 2013 SynCardia Systems, Inc. ... only FDA, Health Canada and CE (Europe) approved Total ... in Scotland, which boasts more than 380,000 visitors annually, ... powered by the Freedom® portable driver as part ... most advanced exhibitions of its kind. , “BodyWorks ...
(Date:5/23/2013)... Bed bugs compromised Penn State. ... confirmed it. Meanwhile, My Cleaning Products offered complimentary samples of ... the pests without using harmful chemical elements. , Based ... the affected building was actually a dormitory , My ... made on May 13 and bed bug presence was confirmed ...
Breaking Biology Technology:NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims 2
... Nov. 12, 2010 The current science and experience ... biosimilar pathway for plasma protein therapies. At a public ... urged the United States Food and Drug Administration (FDA) ... a global approach in its evaluation of plasma protein ...
... 2010   Transgenomic, Inc. (OTC Bulletin Board: ... a research and development grant totaling $1,070,453.32 from the U.S. ... Act (the "Act") in immediately available funds. This is among ... Four of the Company,s R&D programs received the highest maximum ...
... 2010 Ardea Biosciences, Inc. (Nasdaq: RDEA ) ... executive officer, will present at the following upcoming investor conferences: ... in New York, NY. Presentation: 1:40 p.m. EST on Tuesday, November ... Care Conference in New York, NY. Presentation: 1:00 p.m. EST ...
Cached Biology Technology:Plasma Protein Therapies Not Suitable for Biosimilars 2Plasma Protein Therapies Not Suitable for Biosimilars 3Plasma Protein Therapies Not Suitable for Biosimilars 4Transgenomic Awarded $1,070,453 From U.S. Government Under the Patient Protection and Affordable Care Act 2Transgenomic Awarded $1,070,453 From U.S. Government Under the Patient Protection and Affordable Care Act 3Ardea Biosciences to Present at Two Upcoming Investor Conferences 2Ardea Biosciences to Present at Two Upcoming Investor Conferences 3
Mouse monoclonal [B314.1 (MAC 387)] to Macrophage L1 protein Calprotectin (rating: ****) ( Abpromise for all tested applications)....
MOUSE ANTI HUMAN CYTOKERATIN 1-8...
Request Info...
... Ether 30% concentration in ... Surfactant. Clear Solution. Recommended ... 1 mL of 30% ... to 400 mL of ...
Biology Products: